R-Biopharm acquires Australian lab equipment manufacturer and molecular biology multiplex specialist AusDiagnostics
Darmstadt, June 7, 2022 – R-Biopharm AG, a leading German biotechnology company operating on a global scale, announced the acquisition of AusDiagnostics. R-Biopharm is expanding its product portfolio with the addition of the Australian specialist and manufacturer of molecular biology multiplex diagnostics, extraction reagents, and laboratory automation equipment. The company is thereby unlocking new market segments in clinical diagnostics and continuing on its path of steady internationalization. “The existing and future molecular biology multiplex analysis platforms for syndrome testing from system supplier AusDiagnostics broadens our molecular biology expertise and perfectly complements our present clinical diagnostics portfolio,” states Christian Dreher, CEO of R-Biopharm. “The acquisition strengthens our position as a reliable partner for system solutions and offers our customers additional options for diagnostics.”
Upon its establishment in 2006, the Australian company introduced its patented Multiplex Tandem PCR (MT-PCR) on the market. The current technology allows the simultaneous detection of up to 24 pathogens or resistance genes from a single sample, thus shortening the lengthy test procedure in human and animal diagnostics as well as environmental, agricultural, and food analysis. The analysis platform is used in laboratories and hospitals throughout the world for detecting a broad range of diseases.
AusDiagnostics CEO Scott Gilroy said that the transaction marked an exciting new chapter for the company: “Both AusDiagnostics and R-Biopharm AG share the same commitment to innovation in the biotechnology space. This acquisition strengthens AusDiagnostics and will accelerate our global presence. We’ve experienced tremendous, industry-leading growth over the past two years, which has been underpinned by our broad suite of innovative products, talented team, and incredible, loyal customers. Joining the R-Biopharm group will allow us to further build on this and continue to deliver exceptional products and service for our Australian and international customers.”
AusDiagnostics currently has 92 employees with offices in New Zealand, the USA, and Great Britain. Its production facilities in Australia and Great Britain supply a steadily growing network of more than 25 distributors and partners around the world – from which R-Biopharm expects further synergy effects for production as well as international service and support in its clinical diagnostics line.
About R-Biopharm
R-Biopharm AG, located in Darmstadt, is one of Germany’s leading biotechnology companies. It considers itself as a pioneer for health and quality of life. The company´s aspiration is to provide the highest possible precision, safety, clarity and certainty with excellent products and solutions – in prevention, therapy and healing. Research and development at R-Biopharm has developed agile processes in order to take on new challenges to accompany a steadily growing world population into a new health era with sustainable solutions.
As an internationally recognized leader, R-Biopharm stands for the development of excellent technologies, products and solutions in the fields of Clinical Diagnostics, Nutrition Care and Food and Feed Analytics. R-Biopharm is the global market leader for test systems in the field of allergen analysis. The biotechnology company is known for its products that are of high importance for human health. To this end, it unites development, production and sales under one roof and is successfully represented in more than 120 countries worldwide – through 28 subsidiaries and 120 distributors. Founded in 1988, the family-run company employs a total of around 1,300 people worldwide (690 at its headquarters in Darmstadt) and was repeatedly recognized with the “Sustainability Award” for sustainable and profitable growth. R-Biopharm is cultivating a value-oriented corporate culture and management and is family-run in the second generation. The Chairman of the Board of Directors is Christian Dreher.
Press contact:
Simone Feiler
Head of Corporate Brand Communication
https://r-biopharm.com/
https://r-biopharm.com/news-press/download-gallery/
R-Biopharm AG
An der neuen Bergstraße 17
64297 Darmstadt, Germany
Tel.: +49 61 51 - 81 02-538
Mobile: +49 160 - 55 273 60
Fax: +49 61 51 - 81 02-40
Email: s.feiler@r-biopharm.de
Bilder
Om news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Følg pressemeldinger fra news aktuell GmbH
Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.
Siste pressemeldinger fra news aktuell GmbH
Börsenverein des Deutschen Buchhandels: Ulli Lust is awarded the German Non-Fiction Prize 2025 for “Die Frau als Mensch”17.6.2025 18:55:00 CEST | Press release
The winner of the German Non-Fiction Prize 2025 is Ulli Lust, for her work “Die Frau als Mensch. Am Anfang der Geschichte” (“Woman as Human. At the Dawn of History”) (Reprodukt).
Gorenje: Gorenje continues long-term partnership with EHF Champions League16.6.2025 12:21:23 CEST | Press release
Appliance brand Gorenje is prolonging its involvement in the premium club competitions of the European Handball Federation
HEIDELBERG focuses on economic efficiency in FY 2025/26 – operating margin set to rise further5.6.2025 08:53:04 CEST | Press release
Targets for financial year 2024/25 achieved – sales and adjusted EBITDA margin match previous year’s figure Significantly positive free cash flow of € 51 million China Print trade show’s positive impact on orders creates basis for good start to FY 2025/26 Areas with growth potential range from packaging and digital printing to software and lifecycle products Outlook for FY 2025/26 – slight increase in sales expected and adjusted EBITDA margin set to rise to as much as around 8 percent
Longi: What solar efficiency records mean for homeowners - A glance at the future of solar with Back Contact and Tandem technology4.6.2025 11:27:57 CEST | Press release
Frankfurt am Main Solar panels are no longer just a tool for cutting electricity bills. They are becoming a long-term investment in home energy independence. And with every jump in solar cell efficiency, that investment becomes more powerful, compact, and future-ready. This spring, solar technology leader Longi announced not one, but two new world records in solar efficiency. These achievements offer a glimpse of what homeowners might soon see on their rooftops.
Institut auf dem Rosenberg Opens 2026/27 Admissions, Emphasizing Diversity and Individuality Over Sole Academic Merit3.6.2025 10:00:00 CEST | Press release
(St. Gallen, Switzerland) – Institut auf dem Rosenberg, recently ranked as the “Best Boarding School in the World” by Premium Europe, announces the opening of its admissions cycle for the 2026/27 academic year. With all grades currently operating on a waitlist basis, the school continues to attract exceptional applicants, with only a select few gaining direct admission. “Academic excellence is fundamental, but it’s the unique personalities, talents, and perspectives that truly enrich our community,” said Anita Gademann, Board Member and Head of Innovation. “We seek students who not only excel in academics but also bring distinctive qualities that contribute to a vibrant and forward-thinking environment.” Rosenberg’s commitment to individualized education is evident in its unparalleled Talent & Enrichment Programme. Offering over 100 courses – from robotics and artificial intelligence to fashion design and international law – the programme provides students with real-world experiences b
I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.
Besøk vårt presserom